ClinicalTrials.govpublic full text
Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa
cystic fibrosis, respiratory infections, pulmonary cystic fibrosis, amikacin, anti-bacterial agents, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.